Estrogen deficiency accelerates murine autoimmune arthritis associated with receptor activator of nuclear factor-κB ligand-mediated osteoclastogenesis

Endocrinology

Volumn 145, Issue 5, 2004, Pages 2384-2391

  Yoneda, Tomoko ^a   Ishimaru, Naozumi ^a   Arakaki, Rieko ^a   Kobayashi, Masaru ^a   Izawa, Takashi ^a   Moriyama, Keiji ^a   Hayashi, Yoshio ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; DOUBLE STRANDED DNA; ESTROGEN; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RHEUMATOID FACTOR; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HISTOPATHOLOGY; IMMUNOREGULATION; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; TREATMENT OUTCOME;

ANIMALS; ARTHRITIS; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; BONE RESORPTION; CARRIER PROTEINS; CYTOKINES; DISEASE MODELS, ANIMAL; ESTROGENS; FEMALE; GENE EXPRESSION; GLYCOPROTEINS; JOINTS; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MEMBRANE GLYCOPROTEINS; MICE; OSTEOCLASTS; OSTEOPROTEGERIN; OVARIECTOMY; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 2042545404     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-1536     Document Type: Article

References (53)

1. Lahita RG, Bradlow L, Fishman J, HG Kunkel HG 1982 Estrogen metabolism in systemic lupus erythematosus: patients and family members. Arthritis Rheum 25:843-846
2. Zurier RB 1987 Systemic lupus erythematosus. In: Lahita RG, ed. New York: Wiley Publishers; 541-554
3. Daniels T, Whitcher JP 1994 Association of patients of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjögren's syndrome. Arthritis Rheum 37:869-877
4. Davidson A, Diamond B 2001 Autoimmune diseases. N Engl J Med 345:340-350
5. Yamamura Y, Gupta R, Morita Y, He X, Pai R, Endres J, Freiberg A, Chung K, Fox DA 2001 Effector function of resting T cells: activation of synovial fibroblasts. J Immunol 166:2270-2275
6. Park CC, Morel JC, Amin MA, Connors MA, Harlow LA, Koch AE 2001 Evidence of IL-18 as a novel angiogenic mediator. J Immunol 167:1644-1653
7. van den Berg WB 2001 Arguments for interleukin 1 as a target in chronic arthritis. Ann Rheum Dis 59:81-84
8. Pap T, Shigeyama Y, Kuchen S, Fernihough JK, Simmen B, Gay RE, Billingham M, Gay S 2000 Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum 43:1226-1232
9. Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, Koshihara Y, Oda H, Nakamura K, Tanaka S 2000 Involvement of receptor activator of nuclear factor KB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 43:259-269
10. Kotake S, Udagawa N, Hakoda M, Mogi M, Yano K, Tsuda E, Takahashi K, Furuya T, Ishiyama S, Kim KJ, Saito S, Nishikawa T, Takahashi N, Togari A, Tomatsu T, Suda T, Kamatani N 2001 Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum 44:1003-1012
11. Sabokbar A, Fujikawa Y, Neale S, Murray DW, Athanasou NA 1997 Human arthroplasty derived macrophages differentiate into osteoclastic bone resorbing cells. Ann Rheum Dis 56:414-420
12. Rothe L, Collin-Osdoby P, Chen Y, Sunyer T, Chaudhary L, Tsay A, Goldring S, Avioli L, Osdoby P 1998 Human osteoclasts and osteoclast-like cells synthesize and release high basal and inflammatory stimulated levels of the potent chemokine interleukin-8. Endocrinology 139:4353-4363
13. Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, Goldring SR 2000 Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 43:250-258
14. Wong B, Rho J, Arron J, Robinson E, Orlinick J, Chao M, Kalachikov S, Cayani E, Bartlett 3rd FS, Frankel WN, Lee SY, Choi Y 1997 TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem 272:25190-25194
15. Wong BR, Josien R, Choi Y 1999 TRANCE is a TNF family member that regulates dendritic cell and osteoclast function. J Leukoc Biol 65:715-724
16. Josien R, Wong BR, Li HL, Steinman RM, Choi Y 1999 TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J Immunol 162:2562-2568
17. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L 1997 A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175-179
18. Josien R, Li HL, Ingulli E, Sarma S, Wong BR, Vologodskaia BM, Steinman RM, Choi Y 2000 TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo. J Exp Med 191:495-502
19. Bachmann MF, Wong BR, Josien R, Steinman RM, Oxenius A, Choi Y 1999 TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation. J Exp Med 189:1025-1031
20. Wong BR, Josien R, Lee SY, Sauter B, Li HL, Steinman RM, Choi Y 1997 TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 186:2075-2080
21. Cohen PL, Eisenberg RA 1991 Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 9:243-269
22. Theofilopuolos AN, Dixon FJ 1985 Murine models of systemic lupus erythematosus. Adv Immunol 37:269-390
23. Merino R, Iwamoto M, Fossati L, Izui S 1993 Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZBx NZW)F1 and MRL/MpJ-lpr/lpr mice. J Immunol 151:6509-6516
24. Edwards 3rd CK, Zhou T, Zhang J, Baker TJ, De M, Long RE, Borcherding DR, Bowlin TL, Bluethmann H, Mountz JD 1996 Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-α. J Immunol 157:1758-1772
25. lpr mice. J Immunol 167:3486-3493
26. Fields ML, Sokol CL, Eaton-Bassiri A, Seo S, Madaio MP, Erikson J 2001 Fas/fas ligand deficiency results in altered localization of anti-double-stranded DNA B cells and dendritic cells. J Immunol 167:2370-2378
27. Kageyama Y, Koide Y, Yoshida A, Uchijima M, Arai T, Miyamoto S, Ozeki T, Hiyoshi M, Kushida K, Inoue T 1998 Reduced susceptibility to collagen-induced arthritis in mice deficient in IFN-γ receptor. J Immunol 161:1542-1548
28. low T cell subset prevents autoimmune exocrinopathy in murine Sjögren's syndrome. J Immunol 165: 2251-2257
29. Takahashi N, Yamana H, Yoshiki S, Roodman GD, Mundy GR, Jones SJ, Boyde A, Suda T 1998 Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 122:1373-1382
30. Udagawa N, Takahashi N, Akatsu T, Tanaka H, Sasaki T, Nishihara T, Koga T, Martin TJ, Suda T 1990 Origin of osteoclast: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci USA 87:7260-7264
31. Choy EH, Panayi GS 2001 Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344:907-916
32. Lahita RG 1985 Sex steroids and the rheumatic diseases. Arthritis Rheum 28:121-126
33. Bateman A, Singh A, Kral T 1989 The immune-hypothalamic-pituitary-adrenal axis. Endocr Rev 10:92-112
34. Grossman C 1989 Possible underlying mechanisms of sexual dimorphism in the immune response, fact and hypothesis. J Steroid Biochem 34:241-251
35. Holmdahl R, Jansson L, Meyerson B, Klareskog L 1987 Oestrogen induced suppression of collagen arthritis: I. Long term oestradiol treatment of DBA/1 mice reduces severity and incidence of arthritis and decreases the anti-type II collagen immune response. Clin Exp Immunol 70:372-378
36. Masuzawa T, Miura C, Onoe Y, Kusano K, Ohta H, Nozawa S, Suda T 1994 Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow. J Clin Invest 94:1090-1097
37. Verthelyi D, Ahmed SA 1994 17β-estradiol, but not 5α-dihydrotestosterone, augments antibodies to double-stranded deoxyribonucleic acid in nonautoimmune C57BL/6 mice. Endocrinology 135:2615-2622
38. Brick J, Walker S, Wise K 1988 Hormone control to calf thymus nuclear extract (CTE) and DNA in MRL/lpr and MRL/ +/+ mice. Clin Immunol Immunopathol 46:68-81
39. Ralston SH 1994 Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis. J Bone Miner Res 9:883-890
40. Jilka RL, Hangoc G, Girasole G, Passeri G, Manolagas DC 1992 Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257:88-91
41. Fox HS, Bond BL, Parslow TG 1991 Estrogen regulates the IFN-γ promoter. J Immunol 146:4362-4367
42. Cenci S, Toraldo G, Weitzmann N, Roggia C, Gao Y, Qian WP, Sierra O, Pacifici R 2003 Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-γ-induced class II transactivator. Proc Natl Acad Sci USA 100:10405-10410
43. Weitzmann MN, Cenci S, Rifas L, Haug J, Dipersio J, Pacifici R 2001 T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappa B ligand-dependent and -independent mechanisms. J Bone Miner Res 16:328-337
44. Romas E, Bakharevski O, Hards DK, Kartsogiannis V, Quinn JM, Ryan PF, Martin TJ, Gillespie MT 2000 Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis. Arthritis Rheum 43:821-826
45. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM 1999 Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402:304-309
46. Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL 2003 Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 111:1221-1230
47. Kong YY, Penninger JM 2000 Molecular control of bone remodeling and osteoporosis. Exp Gerontol 35:947-956
48. Rodan GA, Martin TJ 2000 Therapeutic approaches to bone diseases. Science 289:1508-1514
49. Merkel KD, Erdmann JM, McHugh KP, Abu-Amer Y, Ross FP, Teitelbaum SL 1999 Tumor necrosis factor-α mediates orthopedic implant osteolysis. Am J Pathol 154:203-210
50. Pacifici R 1996 Estrogen, cytokines and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11:1043-1051
51. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF 1996 Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β. Nat Med 2:1132-1136
52. Oursler MJ, Osdoby P, Pyfferoen J, Riggs BL, Spelsberg TC 1991 Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci USA 88:6613-6617
53. Shevde NK, Bendixen AC, Dienger KM, Pike JW 2000 Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving b-Jun repression. Proc Natl Acad Sci USA 97:7829-7834